Comparing the topical preparations of Indigo naturalis from Chinese and Iranian origin in the treatment of plaque-type psoriasis: A preliminary randomized double-blind pilot study

被引:3
|
作者
Yazdanpanah, Mohammad Javad [1 ]
Vahabi-Amlashi, Sadegh [2 ]
Pishgouy, Marzieh [3 ]
Imani, Mohammad [2 ]
Banihashemi, Mahnaz [2 ]
Mohammadpoor, Amir Hooshang [4 ]
Khajedaluee, Mohammad [5 ]
Bahrami-Taghanaki, Hamidreza [6 ]
Azizi, Hoda [6 ]
机构
[1] Mashhad Univ Med Sci, Cutaneous Leishmaniasis Res Ctr, Imam Reza Hosp, Lib Bldg,Ibn Sina, Mashhad 9137913316, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Imam Reza Hosp, Fac Med, Dept Dermatol, Ibn Sina St, Mashhad 9137913316, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Fac Med, Dept Dermatol, Dermatol,Imam Reza Hosp, Ibn Sina St, Mashhad 9137913316, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Fac Pharm, Dept Clin Pharm, Azadi Sq,Pardis Campus, Mashhad 9188617871, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Fac Med, Dept Community Med, Azadi Sq,Pardis Campus, Mashhad 9188617871, Razavi Khorasan, Iran
[6] Mashhad Univ Med Sci, Sch Persian & Complementary Med, Dept Chinese & Complementary & Med, Azadi Sq,Pardis Campus, Mashhad 9177948564, Razavi Khorasan, Iran
关键词
Psoriasis; Indigo naturalis; Chinese medicine; Randomized Controlled Trial; RECALCITRANT PSORIASIS; OBSERVER-BLIND; OINTMENT;
D O I
10.1016/j.eujim.2021.101310
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Introduction: Psoriasis is an inflammatory and proliferative disease. Indigo naturalis is a blue herbal pigment extracted from Indigofera tinctoria and other plants. The purpose of this study was to compare Iranian ointment made of Indigofera tinctoria with Chinese ointment made of Indigo naturalis from China, and topical betamethasone on the severity of chronic plaque-type psoriasis. Methods: In this preliminary randomized double-blind pilot study, patients with localized chronic plaque-type psoriasis were divided into three groups to receive either topical Iranian herbal ointment, Chinese herbal ointment, or betamethasone ointment twice a day for 8 weeks. Results: At the end of the 8th week of treatment, the mean PASI score in the three groups was 5.8 +/- 3.13, 6.32 +/- 2.85, 3.04 +/- 2.23 for the Chinese, Iranian and betamethasone ointments respectively; and the mean PASI score change from baseline was statistically significant only in the topical betamethasone group ( p = 0.0082). Conclusion: The Iranian herbal ointment used for psoriasis for 8 weeks caused a lower clinical response in comparison with topical betamethasone or the Chinese herbal ointment in the studied patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study
    Oliver, R.
    Krueger, J. G.
    Glatt, S.
    Vajjah, P.
    Mistry, C.
    Page, M.
    Edwards, H.
    Garcet, S.
    Li, X.
    Dizier, B.
    Maroof, A.
    Watling, M.
    el Baghdady, A.
    Baeten, D.
    Ionescu, L.
    Shaw, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 652 - 663
  • [42] Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double-blind, placebo-controlled pilot study
    Fang, Xiu Cai
    Lin, Zhi Hui
    Wu, Yong Dong
    Tian, De An
    Liu, Shi
    Wu, Dong Sheng
    Lin, Han
    Meng, Fan Dong
    Liu, Mei
    Du, Fan
    Shu, Hui Jun
    Wang, Zhi Feng
    Zhuo, Jian Min
    Wang, Ping
    Li, Meng Yu
    Xu, Jian
    JOURNAL OF DIGESTIVE DISEASES, 2023, 24 (11) : 603 - 610
  • [43] A Randomized, Double-Blind, Placebo-Controlled Study of Cilostazol in the Treatment of Nephropathy in Chinese Patients with Type 2 Diabetes
    Luk, Andrea O. Y.
    So, Wing-Yee
    Ozaki, Risa
    Yeung, Chun-Yip
    Choi, Kai
    Kong, Alice P. S.
    Ma, Ronald C. W.
    Chan, Juliana C. N.
    Tong, Peter C. Y.
    DIABETES, 2010, 59 : A252 - A252
  • [44] Add-on effect of PSORI-CM01 to topical calcipotriol for moderate psoriasis vulgaris: A multi-center, randomized, double-blind pilot study
    Parker, Shefton
    Zhang, Anthony Lin
    Zhang, Claire Shuiqing
    Goodman, Greg
    Wen, Zehuai
    Yan, Yuhong
    Yao, Danni
    Wu, Huimei
    Deng, Hao
    Lu, Chuanjian
    Xue, Charlie Changli
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (01):
  • [45] RANDOMIZED DOUBLE-BLIND MULTICENTER STUDY COMPARING ACITRETIN-PUVA, ETRETINATE-PUVA AND PLACEBO-PUVA IN THE TREATMENT OF SEVERE PSORIASIS
    SAURAT, JH
    GEIGER, JM
    AMBLARD, P
    BEANI, JC
    BOULANGER, A
    CLAUDY, A
    FRENK, E
    GUILHOU, JJ
    GROSSHANS, E
    MEROT, Y
    MEYNADIER, J
    TAPERNOUX, B
    DERMATOLOGICA, 1988, 177 (04): : 218 - 224
  • [46] A Prospective, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Type A Botulinum Toxins Botox and Prosigne in the Treatment of Cervical Dystonia
    Aparecida Barasnevicius Quagliato, Elizabeth Maria
    Carelli, Edmur Franco
    Viana, Maura Aparecida
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (01) : 22 - 26
  • [47] Efficacy and safety of acitretin in three fixed doses of 25 mg, 35 mg or 50 mg in patients with severe plaque-type psoriasis: a randomized, double-blind, parallel-group, dose-ranging study
    Dogra, S.
    Jain, A.
    Kaur, I.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 : 47 - 47
  • [48] Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study
    Papp, Kim
    Bachelez, Herve
    Costanzo, Antonio
    Foley, Peter
    Gooderham, Melinda
    Kaur, Primal
    Narbutt, Joanna
    Philipp, Sandra
    Spelman, Lynda
    Weglowska, Jolanta
    Zhang, Nan
    Strober, Bruce
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1093 - 1102
  • [49] Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double-blind, placebo-controlled study
    Seo, Seong Jun
    Shin, Bong Seok
    Lee, Joo-Heung
    Jeong, Haeyoun
    JOURNAL OF DERMATOLOGY, 2021, 48 (06): : 807 - 817
  • [50] Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
    Bissonnette, R.
    Haydey, R.
    Rosoph, L. A.
    Lynde, C. W.
    Bukhalo, M.
    Fowler, J. F.
    Delorme, I.
    Gagne-Henley, A.
    Gooderham, M.
    Poulin, Y.
    Barber, K.
    Jenkin, P.
    Landells, I.
    Pariser, D. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 403 - 410